In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free ...

July 17, 2024 — A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new ... New Study Finds 40-Percent of ...

Discover how dynamic BH3 profiling can predict responses in lung cancer patients to ALK inhibitors, enhancing personalized ...

The Bloomfield woman has made it a mission to educate the public about lung cancer after losing her only son in 2021.

Ivonescimab plus chemotherapy improved survival in advanced squamous NSCLC vs tislelizumab and chemotherapy in a phase 3 ...

The data from the Phase III LUNAR trial, which assessed the device’s treatment efficacy and safety, supported the approval.

Professor Lu Shun, Director of Shanghai lung cancer ... PD-1 combined with chemotherapy remains the global standard of care for first-line treatment of NSCLC. Ivonescimab has once again ...

Veteran actor Sharmila Tagore was diagnosed with zero-stage lung cancer in 2023. Here's what the early-stage diagnosis means, how it was treated, and why early detection matters.

I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Lung cancer is the most common cause ... The standard of care for second-line treatment is also evolving and may include platinum-based chemotherapy for patients who received immune checkpoint ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.